We are live on ! Find out more
IMUX icon

Immunic
IMUX

59 hedge funds and large institutions have $36.9M invested in Immunic in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $34M → $36.9M (+$2.93M)

2% more funds holding

Funds holding: 58 → 59 (+1)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0.09% more ownership

Funds ownership: 5.49% → 5.58% (+0.09%)

90% less call options, than puts

Call options by funds: $55K | Put options by funds: $545K

Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
14
Closed
13
Calls
$55K
Puts
$545K
Net Calls
-$490K
Net Calls Change
-$707K

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$4.69M
2
UOC
UBS O'Connor
Illinois
+$1.27M
3
Millennium Management
Millennium Management
New York
+$989K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$806K
5
RI
RTW Investments
New York
+$804K

Top Sellers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
-$2.52M
2
AFM
Anson Funds Management
Texas
-$931K
3
GPP
Great Point Partners
Connecticut
-$885K
4
RCM
RA Capital Management
Massachusetts
-$885K
5
CAC
Cowen and Company
New York
-$804K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$225K +$92.8K +5,000 +50%
Marshall Wace
27
Marshall Wace
United Kingdom
$200K +$68.6K +3,697 +38%
SSA
28
Schonfeld Strategic Advisors
New York
$198K +$247K +13,300 New
State Street
29
State Street
Massachusetts
$187K +$90.2K +4,860 +63%
BFM
30
Boothbay Fund Management
New York
$175K – – –
Acadian Asset Management
31
Acadian Asset Management
Massachusetts
$164K -$62.9K -3,391 -23%
Northern Trust
32
Northern Trust
Illinois
$146K +$30.2K +1,626 +20%
Bank of America
33
Bank of America
North Carolina
$135K -$624K -33,612 -79%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$129K +$161K +8,691 New
IAM
35
Innovis Asset Management
Illinois
$120K +$150K +8,077 New
XT
36
XTX Topco
Cayman Islands
$105K +$131K +7,077 New
Barclays
37
Barclays
United Kingdom
$102K -$19.7K -1,063 -13%
Simplex Trading
38
Simplex Trading
Illinois
$85K +$28.9K +1,557 +37%
Goldman Sachs
39
Goldman Sachs
New York
$50K +$62.3K +3,357 New
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$41.5K – – –
Prudential Financial
41
Prudential Financial
New Jersey
$40.6K – – –
Bank of New York Mellon
42
Bank of New York Mellon
New York
$40.3K – – –
Charles Schwab
43
Charles Schwab
California
$37.3K +$46.4K +2,500 New
DA
44
Denali Advisors
California
$25.3K – – –
Cetera Investment Advisers
45
Cetera Investment Advisers
Illinois
$23.8K +$29.7K +1,600 New
Fidelity Investments
46
Fidelity Investments
Massachusetts
$19.4K -$2.52K -136 -9%
TRCT
47
Tower Research Capital (TRC)
New York
$19K -$29.7K -1,600 -55%
LFAS
48
Level Four Advisory Services
Texas
$17.6K +$21.9K +1,179 New
Group One Trading
49
Group One Trading
Illinois
$16.3K -$99.4K -5,355 -83%
UBS Group
50
UBS Group
Switzerland
$14.9K +$18.5K +999 +33,300%
1
2
3

IMUX Hedge Fund Activity: Q1 2023 in Review

59 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2023, worth a combined $36.9M — up 8.6% from $34M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IMUX positions and 13 closed out — a net gain of 1 holder — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $4.69M. The largest seller was Commodore Capital, exiting entirely with an estimated $2.52M sold.

  • 59 institutional investors held Immunic (IMUX) as of Q1 2023, up from 58 in Q4 2022.
  • Funds reported $36.9M of Immunic stock for Q1 2023, up 8.6% quarter-over-quarter.
  • 14 funds opened new Immunic positions in Q1 2023 and 13 closed out, a net change of +1 holder.
  • The largest Immunic buyer in Q1 2023 was Deep Track Capital, an estimated $4.69M added.
  • The largest Immunic seller in Q1 2023 was Commodore Capital, an estimated $2.52M sold.

Based on aggregated 13F filings for Q1 2023.